Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Repatha

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RWE Reveals Repatha's Long-Term CV Benefits in Real-World Data
    RWE Reveals Repatha's Long-Term CV Benefits in Real-World Data

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125983606/en/Real-World-Evidence-RWE-Demonstrates-Repathas-Long-Term-Cardiovascular-Benefits

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    India Considers Global Tenders For Key Patented Drugs Due
    India Considers Global Tenders For Key Patented Drugs Due

    23 Nov 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-mulls-floating-global-tenders-for-key-patented-drugs-amid-supply-gaps/articleshow/125509557.cms

    ECONOMICTIMES
    23 Nov 2025
    Share Share
    Amgen to Present Repatha Phase 3 Data at AHA Scientific Sessions
    Amgen to Present Repatha Phase 3 Data at AHA Scientific Sessions

    31 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amgens-landmark-phase-3-repatha-data-to-be-presented-as-late-breaker-at-the-american-heart-association-scientific-sessions-2025-302600739.html

    PR NEWSWIRE
    31 Oct 2025
    Share Share
    AMGEN Launches REPATHA® DIRECT-TO-PATIENT PROGRAM IN U.S.
    AMGEN Launches REPATHA® DIRECT-TO-PATIENT PROGRAM IN U.S.

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amgen-makes-repatha-available-through-amgennow-a-direct-to-patient-program-in-the-us-302575486.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Amgen's Phase III Data Supports FDA Label Expansion Of Repatha
    Amgen's Phase III Data Supports FDA Label Expansion Of Repatha

    05 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha-17937

    INDPHARMAPOST
    05 Oct 2025
    Share Share
    FDA Expands Repatha Use to Adults at Risk of Cardiovascular Event
    FDA Expands Repatha Use to Adults at Risk of Cardiovascular Event

    28 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/fda-expands-repatha-indication-to-adults-at-risk-of-major-cardiovascular-events-from-uncontrolled-ldl-c-17677

    INDPHARMAPOST
    28 Aug 2025
    Share Share